NUF2 interacts with BUB3 and drives lung adenocarcinoma progression through activation of the NF-κB pathway
Authors:
Open Access
- 6 April 2026
- journal article
- research article
- Published by Springer Nature in World Journal of Surgical Oncology
- Vol. 24 (1)
Abstract
Lung adenocarcinoma (LUAD) is the most common form of lung cancer and is often diagnosed at advanced stages. NUF2, a key component of the NDC80 kinetochoreKeywords
Funding Information
- This study was funded by the Shandong Provincial Natural Science Foundation Youth Program (No. ZR2025QC1989Z)
- National Natural Science Foundation of China (No. 82472814)
- the Taishan Scholar Program of Shandong Province (No. ts201712087)
This publication has 33 references indexed in Scilit:
- Majorbio Cloud 2026 provides comprehensive analysis workflows for microbiomeiMeta, 2026
- Feasibility of a ctDNA multigenic panel for non‐small‐cell lung cancer early detection and disease surveillanceMolecular Oncology, 2025
- ATM and IRAK1 orchestrate two distinct mechanisms of NF-κB activation in response to DNA damageNature Structural & Molecular Biology, 2025
- Maintenance of magnesium homeostasis by NUF2 promotes protein synthesis and anaplastic thyroid cancer progressionCell Death & Disease, 2024
- YY2/BUB3 Axis promotes SAC Hyperactivation and Inhibits Colorectal Cancer Progression via Regulating Chromosomal InstabilityAdvanced Science, 2024
- NUF2 regulated the progression of hepatocellular carcinoma through modulating the PI3K/AKT pathway via stabilizing ERBB3Translational Oncology, 2024
- Chronic chromosome instability induced by Plk1 results in immune suppression in breast cancerCell Reports, 2023
- Research progress of Bub3 gene in malignant tumorsCell Biology International, 2021
- The RepID–CRL4 ubiquitin ligase complex regulates metaphase to anaphase transition via BUB3 degradationNature Communications, 2020
- Lung cancer: current therapies and new targeted treatmentsThe Lancet, 2017